Sean McCutcheon
Stock Analyst at Raymond James
(2.81)
# 2,826
Out of 5,182 analysts
12
Total ratings
33.33%
Success rate
16.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBOT BridgeBio Oncology Therapeutics | Initiates: Outperform | $24 | $7.66 | +213.32% | 1 | Jan 9, 2026 | |
| RVMD Revolution Medicines | Maintains: Strong Buy | $72 → $76 | $141.81 | -46.41% | 2 | Oct 17, 2025 | |
| VIR Vir Biotechnology | Initiates: Outperform | $12 | $9.12 | +31.58% | 1 | Jul 11, 2025 | |
| JANX Janux Therapeutics | Initiates: Outperform | $65 | $14.18 | +358.55% | 1 | Jul 11, 2025 | |
| CMPX Compass Therapeutics | Reinstates: Outperform | $9 | $1.83 | +391.80% | 1 | Jul 1, 2025 | |
| BDTX Black Diamond Therapeutics | Reinstates: Outperform | $11 | $2.99 | +267.89% | 1 | Jul 1, 2025 | |
| ENGN enGene Therapeutics | Initiates: Outperform | $23 | $1.50 | +1,433.33% | 1 | Nov 27, 2024 | |
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $12.86 | +211.04% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $76.91 | -8.98% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $28.12 | +205.83% | 1 | Mar 13, 2024 |
BridgeBio Oncology Therapeutics
Jan 9, 2026
Initiates: Outperform
Price Target: $24
Current: $7.66
Upside: +213.32%
Revolution Medicines
Oct 17, 2025
Maintains: Strong Buy
Price Target: $72 → $76
Current: $141.81
Upside: -46.41%
Vir Biotechnology
Jul 11, 2025
Initiates: Outperform
Price Target: $12
Current: $9.12
Upside: +31.58%
Janux Therapeutics
Jul 11, 2025
Initiates: Outperform
Price Target: $65
Current: $14.18
Upside: +358.55%
Compass Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $9
Current: $1.83
Upside: +391.80%
Black Diamond Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $11
Current: $2.99
Upside: +267.89%
enGene Therapeutics
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $1.50
Upside: +1,433.33%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $12.86
Upside: +211.04%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $76.91
Upside: -8.98%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $28.12
Upside: +205.83%